0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Multiplex Assays Market By Type, By Product, By Technology, By Application, By End-User, By Region- Global Opportunity Analysis and Industry Forecast, 2019-2026
Published Date: November 2019
|
Report Code: ALLI-Auto-1B12
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Multiplex Assays Market by Type Nucleic Acid Based Multiplex Assays Planar Nucleic Acid Assays and Bead Based Nucleic Acid Assays Protein Based Multiplex Assays Planar Protein Assays and Bead Based Protein Assays Product Multiplex Assay Reagents Consumables Multiplex Assay Accessories Instruments and Multiplex Assay Software Services Technology Multiplex PCR Multiplex Protein Microarray and Others Application Companion Diagnostics Research Development Drug Development and Biomarker Discovery Validation Clinical Diagnostics Cancer Infectious Diseases Cardiac Diseases Autoimmune Diseases Alzheimers Disease and Others and End User Hospitals Clinical Laboratories Research Institutes and Pharmaceuticals Biotechnological Companies Global Opportunity Analysis and Industry Forecast 2014 2022

Multiplex Assays Market By Type, By Product, By Technology, By Application, By End-User, By Region- Global Opportunity Analysis and Industry Forecast, 2019-2026

Code: ALLI-Auto-1B12
Report
November 2019
180 Pages
Allied Market Research
Region: Global,
Description
Table of Content
Tables & Figures

Multiplex Assays Market Outlook 2026

The global Multiplex Assay Market size accounted for $73.2 million in 2018, and is expected to reach $123.1 million by 2026, growing at a CAGR of 6.6% from 2019 to 2026.
 
A multiplex assay is a procedure in which multiple analytes (proteins, biomolecules, growth factors, cytokines, chemokines, and others) are profiled by detecting and quantifying them simultaneously. These assays are used to amplify multiple targets in a polymerase chain reaction (PCR) experiment and collect more information from minute quantities of proteins or other analytes in lesser time as compared to conventional method, such as ELISA. Multiplex assays are used for pathogen identification, mutation analysis, RNA detection, gene detection analysis, linkage analysis, forensic studies, and others. 
 
The multiplex assays market has witnessed growth owing to increase in R&D activities in pharmaceuticals for the treatment of diseases, such as cancer and Alzheimer’s. Multiplex assays are used in clinical trials as they decrease the cost of research and manual labor, and increase the efficiency of experiment and therapies. In addition, multiplex assays are easier, faster, and automated as compared to conventional methods, thus fuels the market growth. However, high capital investment and dearth of skilled labor hamper the market growth.
 
The global multiplex assays market in this report is studied based on type, product, technology, application, end user, and geography. On the basis of type, it is divided into nucleic acid-based, protein-based multiplex assays, and other multiplex assays; nucleic acid-based and protein-based multiplex assays segment is further bifurcated into planar and bead-based assays. Based on product, it is classified into multiplex assay reagents & consumables, multiplex assay instruments & accessories, and multiplex assay software & services.
 
Based on technology, it is classified into multiplex PCR, multiplex protein microarray, and other technologies. Based on application, it is categorized into companion diagnostics, research & development, and clinical diagnostics. R&D segment is further bifurcated into drug development and biomarker discovery & validation. Clinical diagnostics segment is further subsegmented into cancer, infectious diseases, cardiac diseases, autoimmune diseases, Alzheimer’s disease, and others. On the basis of end user, it is divided into hospitals, clinical laboratories, research institutes, and pharmaceuticals & biotechnological companies. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
 
The key players in the global multiplex assays market are Luminex Corporation, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., QIAGEN N.V., Becton, Dickinson and Company, Abcam PLC., Seegene Inc., Meso Scale Diagnostics, LLC., and Randox Laboratories Ltd. These players adopted product launch, collaboration, and merger & acquisition as their key developmental strategies.
 
Key Benefits
  • The study provides an in-depth analysis of the global multiplex assays market, with current trends and future estimations to elucidate the investment pockets.
  • Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
  • The report provides a quantitative analysis that is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis of different segments (product, type, technology, application, and end user) facilitates in understanding the various type of products and technology used for different applications.
  • Key players are profiled in this report and their strategies are analyzed thoroughly, which predicts the competitive outlook of the market.
 

Multiplex Assay Market Segments:

By Type

  • Nucleic Acid-based Multiplex Assays 
  • Protein-based Multiplex Assays 
  • Others 

By Product

  • Multiplex Assay Reagents & Consumables
  • Multiplex Assay Instruments & Accessories
  • Multiplex Assay Software & Services

By Technology

  • Multiplex PCR
  • Multiplex Protein Microarray
  • Others 

By Application 

  • Companion Diagnostics
  • Research & Development
  • Clinical Diagnostics

End User

  • Hospitals
  • Clinical Laboratories
  • Research Institutes
  • Pharmaceuticals & Biotechnological Companies

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA 
    • Saudi Arabia
    • South Africa
    • Brazil
    • Rest of LAMEA

Table of Content

 

CHAPTER 1:    INTRODUCTION

1.1.    Report description
1.2.    Key benefits for stakeholders
1.3.    Key market segments
1.4.    Research methodology

1.4.1.    Secondary research
1.4.2.    Primary research
1.4.3.    Analyst Tools and Models

CHAPTER 2:    EXECUTIVE SUMMARY

2.1.    Key findings of the study
2.2.    CXO perspective

CHAPTER 3:    MARKET OVERVIEW

3.1.    Market definition and scope
3.2.    Key findings

3.2.1.    Top investment pockets

3.3.    Porter’s five forces analysis

3.3.1.    Moderate bargaining power of buyers
3.3.2.    Low bargaining power of suppliers
3.3.3.    Moderate threat of substitutes
3.3.4.    Low threat of new entrants
3.3.5.    Moderate competitive rivalry

3.4.    Market share analysis, 2018
3.5.    Market dynamics

3.5.1.    Drivers

3.5.1.1.    Increase in R&D activities & governmental funding
3.5.1.2.    Surge in adoption of multiplex assays to reduce operation costs
3.5.1.3.    Rise in adoption of personalized medicines

3.5.2.    Restraint

3.5.2.1.    Lack of skilled labor/healthcare professionals

3.5.3.    Opportunity

3.5.3.1.    Various growth opportunities in emerging economies

CHAPTER 4:    MULTIPLEX ASSAYS MARKET, BY TYPE

4.1.    Overview

4.1.1.    Market size and forecast

4.2.    Nucleic acid-based multiplex assays

4.2.1.    Key market trends and opportunities
4.2.2.    Market size and forecast
4.2.3.    Market share analysis, by country

4.3.    Protein-based multiplex assays

4.3.1.    Key market trends and opportunities
4.3.2.    Market size and forecast
4.3.3.    Market share analysis, by country

4.4.    Others

4.4.1.    Key market trends and opportunities
4.4.2.    Market size and forecast
4.4.3.    Market share analysis, by country

CHAPTER 5:    MULTIPLEX ASSAYS MARKET, BY PRODUCT

5.1.    Overview

5.1.1.    Market size and forecast

5.2.    Multiplex assays reagents & consumables

5.2.1.    Key market trends, growth factors, and opportunities
5.2.2.    Market size and forecast
5.2.3.    Market share analysis, by country

5.3.    Multiplex assays instruments & accessories

5.3.1.    Key market trends, growth factors, and opportunities
5.3.2.    Market size and forecast
5.3.3.    Market share analysis, by country

5.4.    Multiplex assay software & services

5.4.1.    Key market trends, growth factors, and opportunities
5.4.2.    Market size and forecast
5.4.3.    Market share analysis, by country

CHAPTER 6:    MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY

6.1.    Overview

6.1.1.    Market size and forecast

6.2.    Multiplex PCR

6.2.1.    Key market trends, growth factors, and opportunities
6.2.2.    Market size and forecast
6.2.3.    Market share analysis, by country

6.3.    Multiplex protein microarray

6.3.1.    Key market trends, growth factors, and opportunities
6.3.2.    Market size and forecast
6.3.3.    Market share analysis, by country
6.3.4.    Immunohistochemistry

6.3.4.1.    Market size and forecast

6.4.    Other technologies

6.4.1.    Key market trends, growth factors, and opportunities
6.4.2.    Market size and forecast
6.4.3.    Market share analysis, by country

CHAPTER 7:    MULTIPLEX ASSAYS MARKET, BY APPLICATION

7.1.    Overview

7.1.1.    Market size and forecast

7.2.    Companion diagnostics

7.2.1.    Key market trends, growth factors, and opportunities
7.2.2.    Market size and forecast
7.2.3.    Market share analysis, by country

7.3.    Research & development

7.3.1.    Key market trends, growth factors, and opportunities
7.3.2.    Market size and forecast
7.3.3.    Market share analysis, by country

7.4.    Clinical diagnostics

7.4.1.    Key market trends, growth factors, and opportunities
7.4.2.    Market size and forecast
7.4.3.    Market share analysis, by country

CHAPTER 8:    MULTIPLEX ASSAYS MARKET, BY END-USER

8.1.    Overview

8.1.1.    Market size and forecast

8.2.    Hospitals

8.2.1.    Key market trends, growth factors, and opportunities
8.2.2.    Market size and forecast
8.2.3.    Market share analysis, by country

8.3.    Clinical laboratories

8.3.1.    Key market trends, growth factors, and opportunities
8.3.2.    Market size and forecast
8.3.3.    Market share analysis, by country

8.4.    Research institutes

8.4.1.    Key market trends, growth factors, and opportunities
8.4.2.    Market size and forecast
8.4.3.    Market share analysis, by country

8.5.    Pharmaceuticals & biotechnology companies

8.5.1.    Key market trends, growth factors, and opportunities
8.5.2.    Market size and forecast
8.5.3.    Market share analysis, by country

CHAPTER 9:    MULTIPLEX ASSAYS MARKET, BY REGION

9.1.    Overview

9.1.1.    Market size and forecast

9.2.    North America

9.2.1.    Key market trends and opportunities
9.2.2.    Market size and forecast, by country
9.2.3.    Market size and forecast, by type
9.2.4.    Market size and forecast, by product
9.2.5.    Market size and forecast, by technology
9.2.6.    Market size and forecast, by application
9.2.7.    Market size and forecast, by end user

9.2.8.    U.S.

9.2.8.1.    U.S. market size and forecast, by type
9.2.8.2.    U.S. market size and forecast, by product
9.2.8.3.    U.S. market size and forecast, by technology
9.2.8.4.    U.S. market size and forecast, by application
9.2.8.5.    U.S. market size and forecast, by end user

9.2.9.    Canada

9.2.9.1.    Canada market size and forecast, by type
9.2.9.2.    Canada market size and forecast, by product
9.2.9.3.    Canada market size and forecast, by technology
9.2.9.4.    Canada market size and forecast, by application
9.2.9.5.    Canada market size and forecast, by end user

9.2.10.    Mexico

9.2.10.1.    Mexico market size and forecast, by type
9.2.10.2.    Mexico market size and forecast, by product
9.2.10.3.    Mexico market size and forecast, by technology
9.2.10.4.    Mexico market size and forecast, by application
9.2.10.5.    Mexico market size and forecast, by end user

9.3.    Europe

9.3.1.    Key growth factors and opportunities
9.3.2.    Market size and forecast, by country
9.3.3.    Market size and forecast, by type
9.3.4.    Market size and forecast, by product
9.3.5.    Market size and forecast, by technology
9.3.6.    Market size and forecast, by application
9.3.7.    Market size and forecast, by end user

9.3.8.    Germany

9.3.8.1.    Germany market size and forecast, by type
9.3.8.2.    Germany market size and forecast, by product
9.3.8.3.    Germany market size and forecast, by technology
9.3.8.4.    Germany market size and forecast, by application
9.3.8.5.    Germany market size and forecast, by end user

9.3.9.    France

9.3.9.1.    France market size and forecast, by type
9.3.9.2.    France market size and forecast, by product
9.3.9.3.    France market size and forecast, by technology
9.3.9.4.    France market size and forecast, by application
9.3.9.5.    France market size and forecast, by end user

9.3.10.    UK

9.3.10.1.    UK market size and forecast, by type
9.3.10.2.    UK market size and forecast, by product
9.3.10.3.    UK market size and forecast, by technology
9.3.10.4.    UK market size and forecast, by application
9.3.10.5.    UK market size and forecast, by end user

9.3.11.    Italy

9.3.11.1.    Italy market size and forecast, by type
9.3.11.2.    Italy market size and forecast, by product
9.3.11.3.    Italy market size and forecast, by technology
9.3.11.4.    Italy market size and forecast, by application
9.3.11.5.    Italy market size and forecast, by end user

9.3.12.    Spain

9.3.12.1.    Spain market size and forecast, by type
9.3.12.2.    Spain market size and forecast, by product
9.3.12.3.    Spain market size and forecast, by technology
9.3.12.4.    Spain market size and forecast, by application
9.3.12.5.    Spain market size and forecast, by end user

9.3.13.    Rest of Europe

9.3.13.1.    Rest of Europe market size and forecast, by type
9.3.13.2.    Rest of Europe market size and forecast, by product
9.3.13.3.    Rest of Europe market size and forecast, by technology
9.3.13.4.    Rest of Europe market size and forecast, by application
9.3.13.5.    Rest of Europe market size and forecast, by end user

9.4.    Asia-Pacific

9.4.1.    Key growth factors and opportunities.
9.4.2.    Market size and forecast, by country
9.4.3.    Market size and forecast, by type
9.4.4.    Market size and forecast, by product
9.4.5.    Market size and forecast, by technology
9.4.6.    Market size and forecast, by application
9.4.7.    Market size and forecast, by end user

9.4.8.    Japan

9.4.8.1.    Japan market size and forecast, by type
9.4.8.2.    Japan market size and forecast, by product
9.4.8.3.    Japan market size and forecast, by technology
9.4.8.4.    Japan market size and forecast, by application
9.4.8.5.    Japan market size and forecast, by end user

9.4.9.    China

9.4.9.1.    China market size and forecast, by type
9.4.9.2.    China market size and forecast, by product
9.4.9.3.    China market size and forecast, by technology
9.4.9.4.    China market size and forecast, by application
9.4.9.5.    China market size and forecast, by end user

9.4.10.    India

9.4.10.1.    India market size and forecast, by type
9.4.10.2.    India market size and forecast, by product
9.4.10.3.    India market size and forecast, by technology
9.4.10.4.    India market size and forecast, by application
9.4.10.5.    India market size and forecast, by end user

9.4.11.    Rest of Asia-Pacific

9.4.11.1.    Rest of Asia-Pacific market size and forecast, by type
9.4.11.2.    Rest of Asia-Pacific market size and forecast, by product
9.4.11.3.    Rest of Asia-Pacific market size and forecast, by technology
9.4.11.4.    Rest of Asia-Pacific market size and forecast, by application
9.4.11.5.    Rest of Asia-Pacific market size and forecast, by end user

9.5.    LAMEA

9.5.1.    Key growth factors and opportunities
9.5.2.    Market size and forecast, by country
9.5.3.    Market size and forecast, by type
9.5.4.    Market size and forecast, by product
9.5.5.    Market size and forecast, by technology
9.5.6.    Market size and forecast, by application
9.5.7.    Market size and forecast, by end user
9.5.8.    Brazil

9.5.8.1.    Brazil market size and forecast, by type
9.5.8.2.    Brazil market size and forecast, by product
9.5.8.3.    Brazil market size and forecast, by technology
9.5.8.4.    Brazil market size and forecast, by application
9.5.8.5.    Brazil market size and forecast, by end user

9.5.9.    Saudi Arabia

9.5.9.1.    Saudi Arabia market size and forecast, by type
9.5.9.2.    Saudi Arabia market size and forecast, by product
9.5.9.3.    Saudi Arabia market size and forecast, by technology
9.5.9.4.    Saudi Arabia market size and forecast, by application
9.5.9.5.    Saudi Arabia market size and forecast, by end user

9.5.10.    South Africa

9.5.10.1.    South Africa market size and forecast, by type
9.5.10.2.    South Africa market size and forecast, by product
9.5.10.3.    South Africa market size and forecast, by technology
9.5.10.4.    South Africa market size and forecast, by application
9.5.10.5.    South Africa market size and forecast, by end user

9.5.11.    Rest of LAMEA

9.5.11.1.    Rest of LAMEA market size and forecast, by type
9.5.11.2.    Rest of LAMEA market size and forecast, by product
9.5.11.3.    Rest of LAMEA market size and forecast, by technology
9.5.11.4.    Rest of LAMEA market size and forecast, by application
9.5.11.5.    Rest of LAMEA market size and forecast, by end user

CHAPTER 10:    COMPANY PROFILES

10.1.    ABCAM PLC.

10.1.1.    Company overview
10.1.2.    Company snapshot
10.1.3.    Operating business segments
10.1.4.    Product portfolio
10.1.5.    Business performance

10.2.    BECTON, DICKINSON AND COMPANY

10.2.1.    Company overview
10.2.2.    Company snapshot
10.2.3.    Operating business segments
10.2.4.    Product portfolio
10.2.5.    Business performance

10.3.    MESO SCALE DIAGNOSTICS, LLC.

10.3.1.    Company overview
10.3.2.    Company snapshot
10.3.3.    Operating business segments
10.3.4.    Product portfolio
10.3.5.    Key strategic moves and developments

10.4.    RANDOX LABORATORIES LTD.

10.4.1.    Company overview
10.4.2.    Company snapshot
10.4.3.    Operating business segments
10.4.4.    Product portfolio

10.5.    SEEGENE INC.

10.5.1.    Company overview
10.5.2.    Company snapshot
10.5.3.    Operating business segments
10.5.4.    Product Portfolio
10.5.5.    Business performance
10.5.6.    Key strategic moves and developments

10.6.    BIO-RAD LABORATORIES, INC.

10.6.1.    Company overview
10.6.2.    Company snapshot
10.6.3.    Operating business segments
10.6.4.    Product Portfolio
10.6.5.    Business performance

10.7.    ILLUMINA, INC.

10.7.1.    Company overview
10.7.2.    Company snapshot
10.7.3.    Operating business segments
10.7.4.    Product portfolio
10.7.5.    Business performance

10.8.    QIAGEN N.V.

10.8.1.    Company overview
10.8.2.    Company snapshot
10.8.3.    Operating business segments
10.8.4.    Business performance
10.8.5.    Key strategic moves and developments

10.9.    THERMO FISHER SCIENTIFIC, INC.

10.9.1.    Company overview
10.9.2.    Company snapshot
10.9.3.    Operating business segments
10.9.4.    Product portfolio
10.9.5.    Business performance

10.10.    LUMINEX CORPORATION

10.10.1.    Company overview
10.10.2.    Company snapshot
10.10.3.    Operating business segments
10.10.4.    Product portfolio
10.10.5.    Business performance

List of Tables & Figures

 

Table 01.    Global Multiplex Assays Market, By Type, 2018-2026 ($Million)

Table 02.    Nucleic Acid-based Multiplex Assays Market, By Region, 2018-2026 ($Million)

Table 03.    Protein-based Multiplex Assays Market, By Region, 2018-2026 ($Million)

Table 04.    Other Multiplex Assays Market, By Region, 2018-2026 ($Million)

Table 05.    Multiplex Assay Reagents & Consumables Market, By Region, 2018-2026 ($Million)

Table 06.    Multiplex Assay Reagents & Consumables Market, By Region, 2018-2026 ($Million)

Table 07.    Multiplex Assay Instruments & Accessories Market, By Region, 2018-2026 ($Million)

Table 08.    Multiplex Assay Software And Services Market, By Region, 2018-2026 ($Million)

Table 09.    Global Multiplex Assays Market, By Technology, 2018-2026 ($Million)

Table 10.    Multiplex Pcr Assays Market, By Region, 2018-2026 ($Million)

Table 11.    Multiplex Assays Market For Protein Microarray/ Immunohistochemistry, By Region, 2018-2026 ($Million)

Table 12.    Immunohistochemistry (Ihc) Multiplex Assays Market, Key Players

Table 13.    Multiplex Assays Market For Immunohistochemistry, By Region, 2018-2026 ($Million)

Table 14.    Multiplex Assays Market For Other Technologies, By Region, 2018-2026 ($Million)

Table 15.    Multiplex Assay Reagents & Consumables Market, By Region, 2018-2026 ($Million)

Table 16.    Multiplex Assays Market For Companion Diagnostics, By Region, 2018-2026 ($Million)

Table 17.    Multiplex Assays Market For Research & Development, By Region, 2018-2026 ($Million)

Table 18.    Multiplex Assays Market For Clinical Diagnostics, By Region, 2018-2026 ($Million)

Table 19.    Global Multiplex Assays Market, By End User, 2018-2026 ($Million)

Table 20.    Multiplex Assays Market For Hospitals, By Region, 2018-2026 ($Million)

Table 21.    Multiplex Assays Market For Clinical Laboratories, By Region, 2018-2026 ($Million)

Table 22.    Multiplex Assays Market For Research Institutes, By Region, 2018-2026 ($Million)

Table 23.    Multiplex Assays Market For Pharmaceutical & Biotechnology Companies, By Region, 2018-2026 ($Million)

Table 24.    Multiplex Assays Market, By Region, 2018-2026 ($Million)

Table 25.    North America Multiplex Assays Market, By Country, 2018-2026 ($Million)

Table 26.    North America Multiplex Assays Market, By Type, 2018-2026 ($Million)

Table 27.    North America Multiplex Assays Market, By Product, 2018–2026 ($Million),

Table 28.    North America Multiplex Assays Market, By Technology, 2018-2026 ($Million)

Table 29.    North America Multiplex Assays Market, By Application, 2018-2026 ($Million)

Table 30.    North America Multiplex Assays Market, By End User, 2018-2026 ($Million)

Table 31.    U.S. Multiplex Assays Market By Type, 2018-2026 ($Million)

Table 32.    U.S. Multiplex Assays Market By Product, 2018-2026 ($Million)

Table 33.    U.S. Multiplex Assays Market By Technology, 2018-2026 ($Million)

Table 34.    U.S. Multiplex Assays Market By Application, 2018-2026 ($Million)

Table 35.    U.S. Multiplex Assays Market By End User, 2018-2026 ($Million)

Table 36.    Canada Multiplex Assays Market, By Type, 2018-2026 ($Million)

Table 37.    Canada Multiplex Assays Market, By Product, 2018-2026 ($Million)

Table 38.    Canada Multiplex Assays Market, By Technology, 2018-2026 ($Million)

Table 39.    Canada Multiplex Assays Market, By Application, 2018-2026 ($Million)

Table 40.    Canada Multiplex Assays Market, By End User, 2018-2026 ($Million)

Table 41.    Mexico Multiplex Assays Market, By Type, 2018-2026 ($Million)

Table 42.    Mexico Multiplex Assays Market, By Product, 2018-2026 ($Million)

Table 43.    Mexico Multiplex Assays Market, By Technology, 2018-2026 ($Million)

Table 44.    Mexico Multiplex Assays Market, By Application, 2018-2026 ($Million)

Table 45.    Mexico Multiplex Assays Market, By End User, 2018-2026 ($Million)

Table 46.    Europe Multiplex Assays Market, By Country, 2018-2026 ($Million)

Table 47.    Europe Multiplex Assays Market, By Type, 2018-2026 ($Million)

Table 48.    Europe Multiplex Assays Market, By Product, 2018–2026 ($Million),

Table 49.    Europe Multiplex Assays Market, By Technology, 2018-2026 ($Million)

Table 50.    Europe Multiplex Assays Market, By Application, 2018-2026 ($Million)

Table 51.    Europe Multiplex Assays Market, By End User 2018-2026 ($Million)

Table 52.    Germany Multiplex Assays Market, By Type, 2018-2026 ($Million)

Table 53.    Germany Multiplex Assays Market, By Product, 2018-2026 ($Million)

Table 54.    Germany Multiplex Assays Market, By Technology, 2018-2026 ($Million)

Table 55.    Germany Multiplex Assays Market, By Application, 2018-2026 ($Million)

Table 56.    Germany Multiplex Assays Market, By End User, 2018-2026 ($Million)

Table 57.    France Multiplex Assays Market, By Type, 2018-2026 ($Million)

Table 58.    France Multiplex Assays Market, By Product, 2018-2026 ($Million)

Table 59.    France Multiplex Assays Market, By Technology, 2018-2026 ($Million)

Table 60.    France Multiplex Assays Market, By Application, 2018-2026 ($Million)

Table 61.    France Multiplex Assays Market, By End User, 2018-2026 ($Million)

Table 62.    U.K. Multiplex Assays Market, By Type, 2018-2026 ($Million)

Table 63.    U.K. Multiplex Assays Market, By Product, 2018-2026 ($Million)

Table 64.    U.K. Multiplex Assays Market, By Technology, 2018-2026 ($Million)

Table 65.    U.K. Multiplex Assays Market, By Application, 2018-2026 ($Million)

Table 66.    U.K. Multiplex Assays Market, By End User, 2018-2026 ($Million)

Table 67.    Italy Multiplex Assays Market, By Type, 2018-2026 ($Million)

Table 68.    Italy Multiplex Assays Market, By Product, 2018-2026 ($Million)

Table 69.    Italy Multiplex Assays Market, By Technology, 2018-2026 ($Million)

Table 70.    Italy Multiplex Assays Market, By Application, 2018-2026 ($Million)

Table 71.    Italy Multiplex Assays Market, By End User, 2018-2026 ($Million)

Table 72.    Spain Multiplex Assays Market, By Type, 2018-2026 ($Million)

Table 73.    Spain Multiplex Assays Market, By Product, 2018-2026 ($Million)

Table 74.    Spain Multiplex Assays Market, By Technology, 2018-2026 ($Million)

Table 75.    Spain Multiplex Assays Market, By Application, 2018-2026 ($Million)

Table 76.    Spain Multiplex Assays Market, By End User, 2018-2026 ($Million)

Table 77.    Rest Of Europe Multiplex Assays Market, By Type, 2018-2026 ($Million)

Table 78.    Rest Of Europe Multiplex Assays Market, By Product, 2018-2026 ($Million)

Table 79.    Rest Of Europe Multiplex Assays Market, By Technology, 2018-2026 ($Million)

Table 80.    Rest Of Europe Multiplex Assays Market, By Application, 2018-2026 ($Million)

Table 81.    Rest Of Europe Multiplex Assays Market, By End User, 2018-2026 ($Million)

Table 82.    Asia-pacific Multiplex Assays Market, By Country, 2018-2026 ($Million)

Table 83.    Asia-pacific Multiplex Assays Market, By Type, 2018-2026 ($Million)

Table 84.    Asia-pacific Multiplex Assays Market, By Product, 2018–2026 ($Million),

Table 85.    Asia-pacific Multiplex Assays Market, By Technology, 2018-2026 ($Million)

Table 86.    Asia-pacific Multiplex Assays Market, By Application, 2018-2026 ($Million)

Table 87.    Asia-pacific Multiplex Assays Market, By End User, 2018-2026 ($Million)

Table 88.    Japan Multiplex Assays Market, By Type, 2018-2026 ($Million)

Table 89.    Japan Multiplex Assays Market, By Product, 2018-2026 ($Million)

Table 90.    Japan Multiplex Assays Market, By Technology, 2018-2026 ($Million)

Table 91.    Japan Multiplex Assays Market, By Application, 2018-2026 ($Million)

Table 92.    Japan Multiplex Assays Market, By End User, 2018-2026 ($Million)

Table 93.    China Multiplex Assays Market, By Type, 2018-2026 ($Million)

Table 94.    China Multiplex Assays Market, By Product, 2018-2026 ($Million)

Table 95.    China Multiplex Assays Market, By Technology, 2018-2026 ($Million)

Table 96.    China Multiplex Assays Market, By Application, 2018-2026 ($Million)

Table 97.    China Multiplex Assays Market, By End User, 2018-2026 ($Million)

Table 98.    India Multiplex Assays Market, By Type, 2018-2026 ($Million)

Table 99.    India Multiplex Assays Market, By Product, 2018-2026 ($Million)

Table 100.    India Multiplex Assays Market, By Technology, 2018-2026 ($Million)

Table 101.    India Multiplex Assays Market, By Application, 2018-2026 ($Million)

Table 102.    India Multiplex Assays Market, By End User, 2018-2026 ($Million)

Table 103.    Rest Of Asia-pacific Multiplex Assays Market, By Type, 2018-2026 ($Million)

Table 104.    Rest Of Asia-pacific Multiplex Assays Market, By Product, 2018-2026 ($Million)

Table 105.    Rest Of Asia-pacific Multiplex Assays Market, By Technology, 2018-2026 ($Million)

Table 106.    Rest Of Asia-pacific Multiplex Assays Market, By Application, 2018-2026 ($Million)

Table 107.    Rest Of Asia-pacific Multiplex Assays Market, By End User, 2018-2026 ($Million)

Table 108.    Lamea Multiplex Assays Market, By Country, 2018-2026 ($Million)

Table 109.    Lamea Multiplex Assays Market, By Type, 2018-2026 ($Million)

Table 110.    Lamea Multiplex Assays Market, By Product, 2018–2026 ($Million),

Table 111.    Lamea Multiplex Assays Market, By Technology, 2018-2026 ($Million)

Table 112.    Lamea Multiplex Assays Market, By Application, 2018-2026 ($Million)

Table 113.    Lamea Multiplex Assays Market, By End User, 2018-2026 ($Million)

Table 114.    Brazil Multiplex Assays Market, By Type, 2018-2026 ($Million)

Table 115.    Brazil Multiplex Assays Market, By Product, 2018-2026 ($Million)

Table 116.    Brazil Multiplex Assays Market, By Technology, 2018-2026 ($Million)

Table 117.    Brazil Multiplex Assays Market, By Application, 2018-2026 ($Million)

Table 118.    Brazil Multiplex Assays Market, By End User, 2018-2026 ($Million)

Table 119.    Saudi Arabia Multiplex Assays Market, By Type, 2018-2026 ($Million)

Table 120.    Saudi Arabia Multiplex Assays Market, By Product, 2018-2026 ($Million)

Table 121.    Saudi Arabia Multiplex Assays Market, By Technology, 2018-2026 ($Million)

Table 122.    Saudi Arabia Multiplex Assays Market, By Application, 2018-2026 ($Million)

Table 123.    Saudi Arabia Multiplex Assays Market, By End User, 2018-2026 ($Million)

Table 124.    South Africa Multiplex Assays Market, By Type, 2018-2026 ($Million)

Table 125.    South Africa Multiplex Assays Market, By Product, 2018-2026 ($Million)

Table 126.    South Africa Multiplex Assays Market, By Technology, 2018-2026 ($Million)

Table 127.    South Africa Multiplex Assays Market, By Application, 2018-2026 ($Million)

Table 128.    South Africa Multiplex Assays Market, By End User, 2018-2026 ($Million)

Table 129.    Rest Of Lamea Multiplex Assays Market, By Type, 2018-2026 ($Million)

Table 130.    Rest Of Lamea Multiplex Assays Market, By Product, 2018-2026 ($Million)

Table 131.    Rest Of Lamea Multiplex Assays Market, By Technology, 2018-2026 ($Million)

Table 132.    Rest Of Lamea Multiplex Assays Market, By Application, 2018-2026 ($Million)

Table 133.    Rest Of Lamea Multiplex Assays Market, By End User, 2018-2026 ($Million)

Table 134.    Abcam Plc.: Company Snapshot

Table 135.    Abcam Plc.: Operating Segments

Table 136.    Abbvie Plc.: Product Portfolio

Table 137.    Becton, Dickinson And Company: Snapshot

Table 138.    Becton, Dickinson And Company: Operating Segments

Table 139.    Becton, Dickinson And Company: Product Portfolio

Table 140.    Meso Scale Technologies: Company Snapshot

Table 141.    Msd: Operating Segments

Table 142.    Msd: Product Portfolio

Table 143.    Randox: Company Snapshot

Table 144.    Randox Operating Segments

Table 145.    Randox: Product Portfolio

Table 146.    Seegene: Company Snapshot

Table 147.    Seegene: Operating Segments

Table 148.    Bio-rad: Company Snapshot

Table 149.    Bio-rad: Operating Segments

Table 150.    Bio-rad: Product Portfolio

Table 151.    Illumina: Company Snapshot

Table 152.    Illumina: Operating Segments

Table 153.    Illumina: Product Portfolio

Table 154.    Qiagen: Company Snapshot

Table 155.    Qiagen: Net Sales, 2016–2018 ($Million)

Table 156.    Thermo Fisher: Company Snapshot

Table 157.    Thermo Fisher: Operating Segments

Table 158.    Thermo Fisher: Product Portfolio

Table 159.    Luminex Corporation: Company Snapshot

Table 160.    Luminex Corporation: Operating Segments

Table 161.    Luminex Corporation: Product Portfolio

List Of Figures

Figure 01.    Global Multiplex Assays, Market Segmentation

Figure 02.    Top Investment Pockets

Figure 03.    Market Share Analysis, 2018

Figure 04.    Drivers, Restraint, And Opportunity, Global Multiplex Assays Market

Figure 05.    Comparative Share Analysis Of Nucleic Acid-based Multiplex Assays Market, By Country, 2018 & 2026 (%)

Figure 06.    Comparative Share Analysis Of Protein-based Multiplex Assays Market, By Country, 2018 & 2026 (%)

Figure 07.    Comparative Share Analysis Of Other Multiplex Assays Market, By Country, 2018 & 2026 (%)

Figure 08.    Comparative Share Analysis Of Reagents & Consumables Multiplex Assays Market, By Country, 2018 & 2026 (%)

Figure 09.    Comparative Share Analysis Of Instruments & Accessories Multiplex Assays Market, By Country, 2018 & 2026 (%)

Figure 10.    Comparative Share Analysis Of Software And Services Multiplex Assays Market, By Country, 2018 & 2026 (%)

Figure 11.    Comparative Share Analysis Of Multiplex Pcr Assays Market, By Country, 2018 & 2026 (%)

Figure 12.    Comparative Share Analysis Of Multiplex Protein Microarray/ Immunohistochemistry Market, By Country, 2018 & 2026 (%)

Figure 13.    Comparative Share Analysis Of Other Multiplex Assay Technologies Market, By Country, 2018 & 2026 (%)

Figure 14.    Comparative Share Analysis Of Companion Diagnostics Multiplex Assays Market, By Country, 2018 & 2026 (%)

Figure 15.    Comparative Share Analysis Of Research & Development Multiplex Assays Market, By Country, 2018 & 2026 (%)

Figure 16.    Comparative Share Analysis Of Clinical Diagnostics Multiplex Assays Market, By Country, 2018 & 2026 (%)

Figure 17.    Comparative Share Analysis Of Multiplex Assays Market, For Hospitals, By Country, 2018 & 2026 (%)

Figure 18.    Comparative Share Analysis Of Multiplex Assays Market, For Clinical Laboratories, By Country, 2018 & 2026 (%)

Figure 19.    Comparative Share Analysis Of Multiplex Assays Market, For Research Institutes, By Country, 2018 & 2026 (%)

Figure 20.    Comparative Share Analysis Of Multiplex Assays Market, For Pharmaceutical & Biotechnology Companies, By Country, 2018 & 2026 (%)

Figure 21.    Abcam Plc.: Net Sales, 2016–2018 ($Million)

Figure 22.    Abcam Plc.: Revenue Share By Region, 2018 (%)

Figure 23.    Bd: Net Sales, 2016–2018 ($Million)

Figure 24.    Becton, Dickinson And Company: Revenue Share By Segment, 2018 (%)

Figure 25.    Becton, Dickinson And Company Revenue Share By Region, 2018 (%)

Figure 26.    Seegene: Net Sales, 2016–2018 ($Million)

Figure 27.    Bio-rad: Net Sales, 2016–2018 ($Million)

Figure 28.    Bio-rad: Revenue Share By Segment, 2018 (%)

Figure 29.    Bio-rad: Revenue Share By Region, 2018 (%)

Figure 30.    Illumina: Net Sales, 2016–2018 ($Million)

Figure 31.    Illumina: Revenue Share By Segment, 2018 (%)

Figure 32.    Revenue Share By Region, 2018 (%)

Figure 33.    Qiagen: Revenue Share By Product, 2018 (%)

Figure 34.    Qiagen: Revenue Share By Region, 2018 (%)

Figure 35.    Terumo: Net Sales, 2016–2018 ($Million)

Figure 36.    Thermo Fischer: Revenue Share By Segment, 2018 (%)

Figure 37.    Thermo Fischer: Revenue Share By Region, 2018 (%)

Figure 38.    Luminex Corporation: Net Sales, 2016–2018 ($Million)

Figure 39.    Luminex Corporation: Revenue Share By Region, 2018 (%)

 

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5540
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$6654
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9280
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network

RELATED REPORTS

Global and United States Biologics Drug Development Market Report Forecast 2022 2028
Global and United States Biologics Drug Development Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-5X6010
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Biologics Drug Discovery Market Report Forecast 2022 2028
Global and United States Biologics Drug Discovery Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-0D6239
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Nanopharmaceutical Drugs Market Report Forecast 2022 2028
Global and United States Nanopharmaceutical Drugs Market Report & Forecast 2022-2028

The increasing prevalence of chronic diseases and development of the healthcare infrastructure are promoting the adoption of the novel medicine known as nanomedicine for better efficacy and improved patient outcome.Market Analysis and Insights Global and United States Nanopharmaceutical Drugs MarketThis report focuses on global and United States Nanopharmaceutical Drugs market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Nanopharmaceutical Drugs market size is estimated to be worth US 35330 million in 2022 and is forecast to a readjusted size of US 72540 million by 2028 with a CAGR of 12.7 during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-24J10248
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Polymerase Chain Reaction Technology Market Report Forecast 2022 2028
Global and United States Polymerase Chain Reaction Technology Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-7I6111
Tue Jun 07 00:00:00 UTC 2022

Add to Cart